Abanti Sanyal

Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

N. Segal, J. Neely, S. Suryawanshi, 2024, Journal for ImmunoTherapy of Cancer.